Corey Saba

9PUBLICATIONS
32CO-AUTHORS
Computational physiologyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Veterinary epidemiologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 19, 2026
Innovative In Vitro-In Silico Platform for Dose-Response Modeling in Canine Bladder Cancer: A 3D Organoid- and Mathematics-Based Approach.

Mackenzie Long, Yvonne Peng, Saumya Gade

|Apr 02, 2025
Intratumoural tigilanol tiglate in the multicentre treatment of equine sarcoids and cutaneous melanomas.

Raphael Labens, Corey Saba, Jarred Williams

|Apr 14, 2024
Alternating rabacfosadine and doxorubicin for treatment of naïve canine lymphoma.

Corey F Saba, Timothy M Fan, Brenda S Phillips

|Apr 13, 2022
ALVAC-fIL2, a feline interleukin-2 immunomodulator, as a treatment for sarcoids in horses: A pilot study.

Corey Saba, Randall Eggleston, Andrew Parks

|Oct 16, 2021
A prospective, multi-centre, Veterinary Radiation Therapy Oncology Group study reveals potential efficacy of toceranib phosphate (Palladia) as a primary or adjuvant agent in the treatment of canine nasal carcinoma.

Tara Jean Ehling, Mary Kay Klein, Lauren Smith

|Mar 04, 2021
Retrospective evaluation of intranasal carcinomas in cats treated with external-beam radiotherapy: 42 cases.

Hiroto Yoshikawa, Tracy L Gieger, Corey F Saba

Pageof 2

Frequent Collaborators

1 joint publications

L A Trepanier

1 joint publications

Kristine Burgess

1 joint publications

Hiroto Yoshikawa

1 joint publications

Tracy L Gieger